Tweaking the chemical makeup of hydroxychloroquine beyond COVID-19
While the utility of hydroxychloroquine in the fight against COVID-19 is still unclear, it still helps millions of people around the world manage autoimmune diseases. Mark McLaughlin, a researcher with the WVU School of Pharmacy, and his colleagues are trying out new versions of the drug’s molecular structure to see if they can improve its benefit to patients.